SulNOx Group Valuation
Is 3U4 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3U4 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 3U4's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 3U4's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3U4?
Key metric: As 3U4 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is 3U4's PB Ratio? | |
|---|---|
| PB Ratio | 6.9x |
| Book | UK£9.24m |
| Market Cap | UK£63.81m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 113.3x |
| Enterprise Value/EBITDA | -32.8x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 3U4's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.6x | ||
BNN BRAIN Biotech | 4.4x | 71.5% | €71.4m |
NTG Nabaltec | 0.8x | 4.3% | €123.2m |
2HRA H&R GmbH KGaA | 0.3x | 52.9% | €129.2m |
UZU Uzin Utz | 1x | 2.1% | €250.2m |
3U4 SulNOx Group | 6.9x | n/a | €63.8m |
Price-To-Book vs Peers: 3U4 is expensive based on its Price-To-Book Ratio (6.9x) compared to the peer average (1.6x).
Price to Book Ratio vs Industry
How does 3U4's PB Ratio compare vs other companies in the European Chemicals Industry?
| 8 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 8 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: 3U4 is expensive based on its Price-To-Book Ratio (6.9x) compared to the European Chemicals industry average (1.4x).
Price to Book Ratio vs Fair Ratio
What is 3U4's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 6.9x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 3U4's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Central Asia Metals
UK£282.2m
Operates as a base metals producer.
9C3
UK£1.94
7D
4.3%
1Y
3.7%
Minerals Technologies
US$2.6b
Develops, produces, and markets various mineral, mineral-based, and related systems and services.
MNK
US$74.50
7D
1.4%
1Y
33.0%
African Rainbow Minerals
R31.2b
Through its subsidiaries, operates as a diversified mining and minerals company in South Africa, Malaysia, and Switzerland.
EB9
R8.20
7D
-3.0%
1Y
-4.7%